Industry Briefs

A Crime-Fighting Mass Spectrometer? Extrel Corp., a 25-year-old Pittsburgh company, recently received a $44,000 Phase I grant from the National Institute of Environment Health Services under the Small Business Innovation Research program to investigate a novel approach to detecting and identifying trace contaminants—such as illegal drug and explosives vapors—in the air. Wade L. Fite, founder, chairman of the board, and director of research at Extrel, says, “It looks very inte


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Extrel Corp., a 25-year-old Pittsburgh company, recently received a $44,000 Phase I grant from the National Institute of Environment Health Services under the Small Business Innovation Research program to investigate a novel approach to detecting and identifying trace contaminants—such as illegal drug and explosives vapors—in the air. Wade L. Fite, founder, chairman of the board, and director of research at Extrel, says, “It looks very interesting on paper. The SBIR grant will let us see if it looks good on anything but paper.” The novelty of Extrel’s mass spectrometer lies in its way of preconcentrating the trace contaminants—a method that factors in the gas pressure and flow rate of the sample through the system, as well as the amount of time spent on collecting and then purging the sample throughout the system. Fite says the goal is to detect “extremely low concentrations in a relatively short time.”" One application of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio